Design, Synthesis, Enzyme-Inhibitory Activity, and Effect on Human Cancer Cells of a Novel Series of Jumonji Domain-Containing Protein 2 Histone Demethylase Inhibitors

Author:

Hamada Shohei1,Suzuki Takayoshi12,Mino Koshiki3,Koseki Koichi3,Oehme Felix4,Flamme Ingo4,Ozasa Hiroki1,Itoh Yukihiro1,Ogasawara Daisuke1,Komaarashi Haruka3,Kato Aiko3,Tsumoto Hiroki1,Nakagawa Hidehiko1,Hasegawa Makoto3,Sasaki Ryuzo5,Mizukami Tamio3,Miyata Naoki1

Affiliation:

1. Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan

2. PRESTO, Japan Science and Technology Agency (JST), 4-1-8 Honcho Kawaguchi, Saitama 332-0012, Japan

3. Graduate School of Bio-Science, Nagahama Institute of Bio-Science and Technology, 1266 Tamura-cho, Nagahama, Shiga 526-0829, Japan

4. Bayer Schering Pharma AG, Institute for Cardiovascular Research, Aprather Weg 18a, D-42096 Wuppertal, Germany

5. Frontier Pharma Inc., 1281-8 Tamura-cho, Nagahama, Shiga 526-0829, Japan

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3